Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
World J Gastroenterol ; 27(38): 6501-6510, 2021 Oct 14.
Artículo en Inglés | MEDLINE | ID: mdl-34720538

RESUMEN

BACKGROUND: Monomorphic epitheliotropic intestinal T-cell lymphoma (MEITL) is a rare primary intestinal T-cell lymphoma, previously known as enteropathy-associated T-cell lymphoma type II. MEITL is an aggressive T-cell lymphoma with a poor prognosis and high mortality rate. The known major complications of MEITL are intestinal perforation and obstruction. Here, we present a case of MEITL that was diagnosed following upper gastrointestinal bleeding from an ulcerative duodenal lesion, with recurrence-free survival for 5 years. CASE SUMMARY: A 68-year-old female was admitted to our hospital with melena and mild anemia. An urgent esophagogastroduodenoscopy (EGD) revealed bleeding from an ulcerative lesion in the transverse part of the duodenum, for which hemostatic treatment was performed. MEITL was diagnosed following repeated biopsies of the lesion, and cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy was administered. She achieved complete remission after eight full cycles of CHOP therapy. At the last follow-up examination, EGD revealed a scarred ulcer and 18Fluorodeoxyglucose (18FDG) positron emission tomography/computed tomography showed no abnormal FDG accumulation. The patient has been in complete remission for 68 mo after initial diagnosis. CONCLUSION: To rule out MEITL, it is important to carefully perform histological examination when bleeding from a duodenal ulcer is observed.


Asunto(s)
Linfoma de Células T Asociado a Enteropatía , Linfoma de Células T , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Biopsia , Ciclofosfamida/uso terapéutico , Doxorrubicina/uso terapéutico , Femenino , Humanos , Melena/etiología , Tomografía Computarizada por Tomografía de Emisión de Positrones , Vincristina/uso terapéutico
2.
Opt Express ; 23(9): 11537-55, 2015 May 04.
Artículo en Inglés | MEDLINE | ID: mdl-25969248

RESUMEN

Giant enhancement of the magneto-optical Kerr effect (MOKE) by surface plasmon polaritons (SPPs) is theoretically shown in a trilayer structure consisting of double-layer dielectrics and a ferromagnetic metal (Al2O3/SiO2/Fe). We calculated the resonant enhancement of the transverse MOKE (TMOKE) and polar MOKE (PMOKE) using the attenuated total reflection (ATR) configuration with the transfer matrix method using a 4 × 4 scattering matrix. At a specific film thickness of the low-index SiO2 layer, where confinement of the SPPs on the Fe surface becomes close to the cutoff condition, the incident light from the Al2O3 couples with the SPPs at the SiO2/Fe boundary most efficiently, resulting in resonant enhancement of the MOKE at an incident angle corresponding to the wave vector of the SPPs. The calculated PMOKE showed orthogonal transformation (90°-rotation) and almost full-orbed deformation (44°-ellipticity) of the polarization, and the TMOKE showed a change in reflectance of about 34 dB upon magnetization reversal.

3.
J Med Virol ; 83(4): 702-9, 2011 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-21328386

RESUMEN

The etiology of cytomegalovirus (CMV), human herpesvirus-6 (HHV-6), and Epstein-Barr virus (EBV) reactivation and the potential for complications following cytotoxic chemotherapy in the absence of allogeneic transplantation are not clearly understood. Patients with adult T cell leukemia (ATL) are susceptible to opportunistic infections. In this study, the incidence, kinetics and clinical significance of reactivation of CMV, HHV-6, and EBV in ATL patients were investigated. Viral DNA in a total of 468 plasma samples from 34 patients was quantified using real-time PCR. The probability of CMV, HHV-6, and EBV reactivation by 100 days after the start of chemotherapy was 50.6%, 52.3%, and 21.6%, respectively. Although most CMV reactivations were self-limited, plasma CMV DNA tended to persist or increase if the CMV DNA levels in plasma reached ≥ 10(4) copies/ml. CMV reactivation was negatively associated with survival, but the P-value for this association was near the borderline of statistical significance (P=0.052). One patient developed fatal interstitial pneumonia concomitant with peak CMV DNA accumulation (1.6 × 10(6) copies/ml plasma). Most HHV-6 and EBV reactivations were self-limited, and no disease resulting from HHV-6 or EBV was confirmed. HHV-6 and EBV reactivation were not associated with reduced survival (P=0.35 and 0.11, respectively). These findings demonstrated that subclinical reactivation of CMV, HHV-6, and EBV were common in ATL patients receiving chemotherapy. There were differences in the viral reactivation patterns among the three viruses. A CMV load ≥ 10(4) copies/ml plasma was indicative of subsequent exacerbation of CMV reactivation and developing serious clinical course.


Asunto(s)
Antineoplásicos/efectos adversos , Infecciones por Citomegalovirus/inducido químicamente , Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos , Infecciones por Virus de Epstein-Barr/inducido químicamente , Leucemia-Linfoma de Células T del Adulto/tratamiento farmacológico , Infecciones por Roseolovirus/inducido químicamente , Activación Viral/efectos de los fármacos , Adulto , Anciano , Anciano de 80 o más Años , Antineoplásicos/administración & dosificación , Infecciones por Citomegalovirus/virología , ADN Viral/sangre , Quimioterapia/métodos , Infecciones por Virus de Epstein-Barr/virología , Femenino , Humanos , Incidencia , Masculino , Persona de Mediana Edad , Reacción en Cadena de la Polimerasa , Infecciones por Roseolovirus/virología
4.
Intern Med ; 49(19): 2157-61, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-20930447

RESUMEN

A 65-year-old woman presented with a 6-month history of abdominal pain and watery diarrhea. Type II enteropathy-associated T-cell lymphoma (EATL) was diagnosed based on the clinical presentation and pathological examination of the tumor. The patient received combination chemotherapy but did not achieve remission. Subsequently, high-dose therapy (HDT) and autologous stem cell transplantation (ASCT) were performed. After these therapies, she achieved complete remission, which has been sustained for 18 months. Although the role of HDT-ASCT for EATL is still controversial, the clinical course of this patient suggests that ASCT can improve the prognosis in some patients with EATL.


Asunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Linfoma de Células T Asociado a Enteropatía/tratamiento farmacológico , Linfoma de Células T Asociado a Enteropatía/terapia , Neoplasias del Yeyuno/tratamiento farmacológico , Neoplasias del Yeyuno/terapia , Trasplante de Células Madre de Sangre Periférica , Anciano , Protocolos de Quimioterapia Combinada Antineoplásica/administración & dosificación , Terapia Combinada , Ciclofosfamida/administración & dosificación , Doxorrubicina/administración & dosificación , Doxorrubicina/análogos & derivados , Femenino , Humanos , Prednisolona/administración & dosificación , Inducción de Remisión , Trasplante Autólogo , Vincristina/administración & dosificación
5.
Intern Med ; 49(13): 1303-6, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-20606364

RESUMEN

We describe a 62-year-old man infected with human immunodeficiency virus (HIV)-1 who developed primary effusion lymphoma (PEL). Pleural effusion contained atypical lymphoid cells with human herpesvirus (HHV)-8 latent nuclear antigen (LANA)(+). Radiological examination revealed pleural and pericardial effusion, but no evidence of tumor mass or lymph node enlargement. The patient was administered with highly active anti retroviral therapy (HAART) and THP-COP therapy, resulting in complete remission. The prevalence of HHV-8 infection among HIV positive individuals is higher than in the general population in Japan. Although PEL is extremely rare in Japan, the incidence might increase in the future.


Asunto(s)
Infecciones por VIH/complicaciones , Infecciones por Herpesviridae/complicaciones , Herpesvirus Humano 8 , Linfoma de Efusión Primaria/diagnóstico , Linfoma de Efusión Primaria/virología , Protocolos de Quimioterapia Combinada Antineoplásica/administración & dosificación , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Terapia Antirretroviral Altamente Activa , Ciclofosfamida/administración & dosificación , Doxorrubicina/administración & dosificación , Doxorrubicina/análogos & derivados , Infecciones por VIH/tratamiento farmacológico , Infecciones por Herpesviridae/tratamiento farmacológico , Humanos , Japón , Linfoma de Efusión Primaria/tratamiento farmacológico , Masculino , Persona de Mediana Edad , Prednisolona/administración & dosificación , Vincristina/administración & dosificación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...